Scopolamine transdermal delivery system
    1.
    发明公开
    Scopolamine transdermal delivery system 失效
    系统zur perkutanen Verabreichung von Scopolamin。

    公开(公告)号:EP0262753A1

    公开(公告)日:1988-04-06

    申请号:EP87305037.1

    申请日:1987-06-08

    发明人: Kim, Benjamin K.

    IPC分类号: A61M37/00 A61L15/03

    摘要: The present invention is directed to a transdermal delivery system for scopolamine. The delivery system is composed of multiple layers (14, 16, 18) containing a varying concentration of scopolamine base. Each layer (14, 16, 18) includes a medically acceptable rubber (such as a butyl rubber), an active substance (such as scopolamine) and a vehicle for the active substance (such as light mineral oil). Beginning with the first layer (in contact with the skin), concentration of the active substance increases from 7 % or less up to 10-16 %. This construction allows the controlled release of the active substance over a sustained period of time.

    摘要翻译: 本发明涉及东莨菪碱的透皮递送系统。 递送系统由含有不同浓度的东莨菪碱碱的多层(14,16,18)组成。 每个层(14,16,18)包括医学上可接受的橡胶(例如丁基橡胶),活性物质(如东莨菪碱)和活性物质(如轻质矿物油)的载体。 从第一层(与皮肤接触)开始,活性物质的浓度从7%或更少增加到10-16%。 这种结构允许在持续的时间内控制活性物质的释放。

    NITROGLYCERIN TRANSDERMAL DELIVERY SYSTEM

    公开(公告)号:EP0224981A3

    公开(公告)日:1988-08-10

    申请号:EP86305511

    申请日:1986-07-17

    发明人: KIM, K. BENJAMIN

    摘要: A transdermal delivery system for a vasoactive substance includes, by weight, about 30 to 70% of a medically-acceptable liquid silicone rubber, about 5 to 25% of a vasoactive substance, about 0.1 to 2.0% of a gelling agent, about 2 to 15% of a material which swells as water is absorbed from the stratum corneum and about 5 to 35% of a mixture comprising one or more solvents, viscosity reducers and skin penetration enhancers including, by weight of the entire delivery system, about 5 to 25% of a solvent, about 0 to 5% of a viscosity reducer and about 5 to 25% of a skin penetration enhancer.

    摘要翻译: 用于血管活性物质的经皮递送系统包括按重量计约30至70%的医学上可接受的液体硅橡胶,约5至25%的血管活性物质,约0.1至2.0%的胶凝剂,约2至 当水从角质层吸收时,15%的物质膨胀,并且包含一种或多种溶剂,粘度降低剂和皮肤渗透增强剂的混合物的约5%至35%,包括按整个递送系统的重量计约5至25 %的溶剂,约0至5%的降粘剂和约5至25%的皮肤渗透促进剂。

    Nitroglycerin transdermal delivery system
    3.
    发明公开
    Nitroglycerin transdermal delivery system 失效
    转铁蛋白Einbringungssystemfür硝酸甘油。

    公开(公告)号:EP0224981A2

    公开(公告)日:1987-06-10

    申请号:EP86305511.7

    申请日:1986-07-17

    发明人: Kim, K. Benjamin

    IPC分类号: A61L15/03 A61K47/00

    摘要: A transdermal delivery system for a vasoactive substance includes, by weight, about 30 to 70% of a medically-acceptable liquid silicone rubber, about 5 to 25% of a vasoactive substance, about 0.1 to 2.0% of a gelling agent, about 2 to 15% of a material which swells as water is absorbed from the stratum corneum and about 5 to 35% of a mixture comprising one or more solvents, viscosity reducers and skin penetration enhancers including, by weight of the entire delivery system, about 5 to 25% of a solvent, about 0 to 5% of a viscosity reducer and about 5 to 25% of a skin penetration enhancer.

    摘要翻译: 用于血管活性物质的透皮递送系统包括约30至70%的医学上可接受的液体硅橡胶,约5至25%的血管活性物质,约0.1至2.0%的胶凝剂,约2至 作为水溶胀的材料的15%从角质层吸收,以及约5至35%的包含一种或多种溶剂的混合物,粘度降低剂和皮肤渗透增强剂,包括按整个递送系统的重量计约5至25 溶剂的%,粘度降低剂的约0至5%和皮肤渗透增强剂的约5至25%。